10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Shares Buyback Ratio % : 63.04 (As of Jun. 10, 2024)

View and export this data going back to 2022. Start your Free Trial

What is 10X Capital Venture Acquisition III Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. 10X Capital Venture Acquisition III's current shares buyback ratio was 63.04%.

10X Capital Venture Acquisition III Shares Buyback Ratio % Historical Data

The historical data trend for 10X Capital Venture Acquisition III's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10X Capital Venture Acquisition III Shares Buyback Ratio % Chart

10X Capital Venture Acquisition III Annual Data

Trend

Dec21

Dec22

Shares Buyback Ratio %

63.04

10X Capital Venture Acquisition III Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Shares Buyback Ratio %	Get a 7-Day Free Trial						-	63.04	-	-	-

10X Capital Venture Acquisition III Shares Buyback Ratio % Calculation

10X Capital Venture Acquisition III's Shares Buyback Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2021 )	-	Shares Outstanding (EOP) (A: Dec. 2022 ))	/	Shares Outstanding (EOP) (A: Dec. 2021 )
	=	(41.153	-	15.2092)	/	41.153
	=	63.04%

10X Capital Venture Acquisition III's Shares Buyback Ratio for the quarter that ended in Sep. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2023 )	-	Shares Outstanding (EOP) (A: Sep. 2023 ))	/	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	(15.2092	-	15.2092)	/	15.2092
	=	0.00%

10X Capital Venture Acquisition III Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of 10X Capital Venture Acquisition III's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » 10X Capital Venture Acquisition Corp III (AMEX:VCXB) » Definitions » Shares Buyback Ratio %

Comparable Companies

BCSA LCW GAQ FLME CHEA EVE HCMA SUAC ALCY HHLA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA

Traded in Other Exchanges

N/A

Address

1 World Trade Center, 85th Floor, New York, NY, USA, 10007

Website

https://www.10xspac.com

10X Capital Venture Acquisition Corp III is a blank check company.

Executives

Kash Sheikh	director	4001 KENNETT PIKE, SUITE 302, WILMINGTON DE 19807
Woodrow Levin	director	535 MISSION STREET, 11TH FLOOR, SAN FRANSISCO CA 941105
Christopher Jurasek	director	13625 TECHNOLOGY DR, EDEN PRAIRIE MN 55344-2252
Oliver Wriedt	officer: See Remarks	CIFC CORP., 250 PARK AVENUE, 4TH FLOOR, NEW YORK NY 10177
David Weisburd	director, officer: COO & Head of Origination	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Guhan Kandasamy	officer: Chief Financial Officer	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Hans Thomas	director, 10 percent owner, officer: Chief Executive Officer	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Boris Silver	director	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
10x Capital Advisors, Llc	10 percent owner	1 WORLD TRADE CENTER, 85TH FLOOR, NEW YORK NY 10007
10x Capital Spac Sponsor Iii Llc	director, 10 percent owner	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NJ 10007

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Headlines

From GuruFocus

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

By GlobeNewswire • 08-10-2023